These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4197209)

  • 1. Myasthenia gravis. Cellular response to basic myelin protein compared with cellular and humoral immunity to muscle antigens.
    Kott E; Rule AH
    Neurology; 1973 Jul; 23(7):745-8. PubMed ID: 4197209
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte response to muscle antigens in myasthenia gravis. Relationship to clinical severity and presence of circulating antibodies.
    Kott E; Genkins G; Rule AH
    Neurology; 1973 Apr; 23(4):374-80. PubMed ID: 4575302
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.
    Behan WM; Behan PO; Simpson JA
    J Neurol Neurosurg Psychiatry; 1975 Nov; 38(11):1039-47. PubMed ID: 1206412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy.
    Kawanami S; Itoyama Y; Kuroiwa Y
    J Neurol; 1976 Jul; 213(1):33-40. PubMed ID: 59796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis.
    Goust JM; Castaigne A; Moulias R
    Clin Exp Immunol; 1974 Sep; 18(1):39-47. PubMed ID: 4478858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in myasthenia gravis: cellular hypersensitivity to skeletal muscle.
    Alpert LI; Rule A; Norio M; Kott E; Kornfeld P; Osserman KE
    Am J Clin Pathol; 1972 Dec; 58(6):647-53. PubMed ID: 4118370
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of cellular immunity using the leukocyte migration test in myasthenia].
    Goust JM; Castaigne A; Moulias R
    Rev Neurol (Paris); 1972 Sep; 127(3):355-62. PubMed ID: 4664656
    [No Abstract]   [Full Text] [Related]  

  • 8. Muscle antibodies in myasthenia gravis.
    Vetters JM
    Immunology; 1967 Sep; 13(3):275-80. PubMed ID: 4861494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte migration response to purified muscle antigen in myasthenia gravis patients.
    Chiu HC; Chen RC; Hung TP; Deng JS
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):977-85. PubMed ID: 6942100
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis: migration inhibition of leucocytes in the presence of central-nervous-tissue antigen and muscle antigens.
    Kott E; Osserman KE; Rule AH
    Lancet; 1971 Oct; 2(7728):816. PubMed ID: 4106628
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunopathology of myasthenia gravis. Comparison of myasthenic sceletal muscle antibodies with rabbit and rat antibodies produced by immunization with skeletal muscle proteins].
    Stroehmann I; Ricken D; Naubereit M; Bruchhausen D
    Res Exp Med (Berl); 1973 May; 160(3):181-95. PubMed ID: 4122532
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W; Cosgrove JB; Robb P
    Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases.
    Behan PO; Behan WM; Feldman RG; Kies MW
    Arch Neurol; 1972 Aug; 27(2):145-52. PubMed ID: 4625188
    [No Abstract]   [Full Text] [Related]  

  • 14. Mast cell sensitizing antibodies in myasthenia gravis.
    Schwartz J; Eyquem A; Vardinon N
    Immunol Commun; 1975; 4(3):243-50. PubMed ID: 809349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis, autoimmunity and the thymus.
    Strauss AJ
    Adv Intern Med; 1968; 14():241-80. PubMed ID: 4178674
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental myasthenia gravis.
    Goldstein G; Hofmann WW
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():241-59. PubMed ID: 4329690
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in myasthenia gravis. Incidence of muscle-precipitating antibodies correlated with positive immunofluorescence.
    Lang RW; Kornfeld P; Weiner LB; Osserman KE
    Am J Clin Pathol; 1969 Feb; 51(2):238-44. PubMed ID: 4974864
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and properties of an acid-soluble muscle antigen reacting with antibodies in myasthenia gravis sera.
    Aarli JA
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(3):453-9. PubMed ID: 4114938
    [No Abstract]   [Full Text] [Related]  

  • 20. Muscle antibodies in myasthenia gravis.
    Andersen P
    Acta Neurol Scand; 1970; 46(S43):213-4. PubMed ID: 4917683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.